The most robust of these studies demonstrated clinical benefits for the treatment of hepatocellular carcinoma, nodular lymphoma and various inoperable tumours that failed to reach statistical significance ( Johnston and Novales, 1962 ; Johnston, 1962 ; Tang et al , 1991 ).
← all excerpts
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.
1
—
—